Cambridge, MA, United States of America

Scott R Manalis

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 420(Granted Patents)


Location History:

  • Cambridge, MA (US) (2002 - 2023)
  • Portland, OR (US) (2023)

Company Filing History:


Years Active: 2002-2023

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: Innovations by Scott R Manalis: Pioneering Advances in Cancer Prevention and Particle Measurement

Introduction: Scott R Manalis, based in Cambridge, MA, is an accomplished inventor with an impressive portfolio of 23 patents. His work primarily focuses on innovative methods and compositions that significantly advance the fields of oncology and particle measurement. Through his inventions, Manalis has aimed to address critical health challenges and improve diagnostic and treatment strategies.

Latest Patents: One of Scott R Manalis's notable recent patents is titled "Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia." This invention outlines comprehensive methods, compositions, and kits for diagnosing and managing hemopoietic malignancies. The detailed approach includes determining cellular mass in samples and identifying molecular signatures, offering hope for better patient outcomes. Additionally, treatment methodologies may include administering BCR-ABL tyrosine kinase inhibitors or various other pharmaceutical formulations.

Another significant patent from Manalis is "Systems and methods for measuring properties of particles." This invention provides systems for measuring mechanical properties of particles, particularly biological entities within fluidic channels. By analyzing acoustic scattering of single particles, the methods enable the measurement of various properties, such as transport rates and cross-linking density. This advancement can have profound implications for scientific research and medical diagnostics.

Career Highlights: Throughout his career, Scott R Manalis has been affiliated with prominent research institutions, including the Massachusetts Institute of Technology (MIT) and Affinity Biosensors, LLC. His work at MIT has enabled him to collaborate with leading scientists and push the boundaries of research in biomechanics and biomedicine. At Affinity Biosensors, LLC, he contributed to pioneering new technologies aimed at enhancing diagnostic capabilities.

Collaborations: Scott R Manalis has partnered with notable colleagues in his field, including Thomas P Burg and Kenneth Babcock. These collaborations have allowed for a vibrant exchange of ideas and have fostered the development of groundbreaking technologies that can significantly impact healthcare and research.

Conclusion: Scott R Manalis's contributions to innovation and invention in the fields of cancer treatment and particle measurement are noteworthy. With a robust portfolio of patents that aim to improve diagnostic and therapeutic strategies, he has established himself as a leading figure in his domain. The impact of his work continues to inspire future advancements and collaborations in research and medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…